Biotech2050 Podcast Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years. Biotech2050 Podcast’s tracks Breaking new ground in the treatment of fibrosis, Bernard Coulie, President & CEO, Pliant Tx by Biotech2050 Podcast published on 2023-08-28T19:28:12Z Transforming medicine through precision epigenomic control, Mahesh Karande, Pres. & CEO, Omega Tx by Biotech2050 Podcast published on 2023-08-09T12:04:21Z Catalyzing the next generation of mRNA medicines, Joseph Payne, Founder, Pres. & CEO, Arcturus Tx by Biotech2050 Podcast published on 2023-08-15T18:43:30Z Advancing muscle biology, Robert Blum, Pres. & CEO, & Fady Malik, EVP, Research & Dev., Cytokinetics by Biotech2050 Podcast published on 2023-08-01T12:31:18Z Transforming the treatment of neuromuscular diseases, James McArthur, CEO, PepGen by Biotech2050 Podcast published on 2023-07-19T19:38:50Z Conquering new frontiers in cell therapy, Paul Lammers, CEO, Triumvira Immunologics by Biotech2050 Podcast published on 2023-07-19T18:23:02Z Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma by Biotech2050 Podcast published on 2023-07-19T14:35:01Z Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx by Biotech2050 Podcast published on 2023-07-19T14:28:23Z
Breaking new ground in the treatment of fibrosis, Bernard Coulie, President & CEO, Pliant Tx by Biotech2050 Podcast published on 2023-08-28T19:28:12Z
Transforming medicine through precision epigenomic control, Mahesh Karande, Pres. & CEO, Omega Tx by Biotech2050 Podcast published on 2023-08-09T12:04:21Z
Catalyzing the next generation of mRNA medicines, Joseph Payne, Founder, Pres. & CEO, Arcturus Tx by Biotech2050 Podcast published on 2023-08-15T18:43:30Z
Advancing muscle biology, Robert Blum, Pres. & CEO, & Fady Malik, EVP, Research & Dev., Cytokinetics by Biotech2050 Podcast published on 2023-08-01T12:31:18Z
Transforming the treatment of neuromuscular diseases, James McArthur, CEO, PepGen by Biotech2050 Podcast published on 2023-07-19T19:38:50Z
Conquering new frontiers in cell therapy, Paul Lammers, CEO, Triumvira Immunologics by Biotech2050 Podcast published on 2023-07-19T18:23:02Z
Next-gen immunotherapies for cancer, Andrew Scharenberg, Co-founder & CEO, Umoja Biopharma by Biotech2050 Podcast published on 2023-07-19T14:35:01Z
Transforming medicine through non-viral gene therapy, Theresa Heah, CEO, Intergalactic Tx by Biotech2050 Podcast published on 2023-07-19T14:28:23Z
